Saivishal Daripelli

Title: The Innovative Contributions of Saivishal Daripelli

Introduction

Saivishal Daripelli is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various sleep and vigilance disorders. With a total of 2 patents to his name, Daripelli's work is paving the way for advancements in medical science.

Latest Patents

Daripelli's latest patents include a method of treatment with histamine-3 receptor inverse agonist. This invention provides new methods for treating conditions such as narcolepsy, excessive daytime sleepiness, obstructive sleep apnea, and other sleep-related disorders. The method involves administering a therapeutically effective amount of histamine-3 receptor (H3R) inverse agonist, specifically N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide or its pharmaceutically acceptable salts. Additionally, he has developed heteroaryl compounds as muscarinic M1 receptor positive allosteric modulators. This invention relates to compounds that serve as M1 PAMs, detailing their preparation, pharmaceutical composition, and usage.

Career Highlights

Saivishal Daripelli is currently associated with Suven Life Sciences Limited, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing new therapeutic methods that address critical health issues.

Collaborations

Daripelli collaborates with esteemed colleagues such as Ramakrishna Nirogi and Anil Karbhari Shinde, enhancing the scope and impact of his research.

Conclusion

Saivishal Daripelli's contributions to the field of pharmaceuticals through his innovative patents are commendable. His work not only addresses significant health challenges but also showcases the potential of scientific research in improving lives.